Bryan Garnier analyst Alex Cogut initiated coverage of MoonLake Immunotherapeutics with a Buy rating and $22 price target.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on MLTX:
Bryan Garnier analyst Alex Cogut initiated coverage of MoonLake Immunotherapeutics with a Buy rating and $22 price target.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on MLTX: